Renier G - Search Results

1

Intervention in diabetic vascular disease by modulation of growth factors.

Serri O, Renier G. Serri O, et al. Among authors: renier g. Metabolism. 1995 Oct;44(10 Suppl 4):83-90. doi: 10.1016/0026-0495(95)90226-0. Metabolism. 1995. PMID: 7476317 Review.

2

Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.

Renier G, Mamputu JC, Serri O. Renier G, et al. Metabolism. 2003 Aug;52(8 Suppl 1):13-8. doi: 10.1016/s0026-0495(03)00212-9. Metabolism. 2003. PMID: 12939734 Review.

3

Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL.

Desfaits AC, Serri O, Renier G. Desfaits AC, et al. Among authors: renier g. Metabolism. 1997 Oct;46(10):1150-6. doi: 10.1016/s0026-0495(97)90208-0. Metabolism. 1997. PMID: 9322798

4

Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium.

Renier G, Desfaits AC, Serri O. Renier G, et al. Metabolism. 2000 Feb;49(2 Suppl 1):17-22. doi: 10.1016/s0026-0495(00)80080-3. Metabolism. 2000. PMID: 10693915

5

Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging.

Renier G, Mamputu JC, Desfaits AC, Serri O. Renier G, et al. J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):20-9. doi: 10.1016/s1056-8727(02)00271-4. J Diabetes Complications. 2003. PMID: 12623165 Clinical Trial.

6

Enhanced lipoprotein lipase secretion and foam cell formation by macrophages of patients with growth hormone deficiency: possible contribution to increased risk of atherogenesis?

Serri O, Li L, Maingrette F, Jaffry N, Renier G. Serri O, et al. Among authors: renier g. J Clin Endocrinol Metab. 2004 Feb;89(2):979-85. doi: 10.1210/jc.2003-030911. J Clin Endocrinol Metab. 2004. PMID: 14764824

7

Effects of acute and prolonged glucose excess on growth hormone release by cultured rat anterior pituitary cells.

Renier G, Serri O. Renier G, et al. Neuroendocrinology. 1991 Nov;54(5):521-5. doi: 10.1159/000125947. Neuroendocrinology. 1991. PMID: 1684230

8

Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.

Desfaits AC, Serri O, Renier G. Desfaits AC, et al. Among authors: renier g. Diabetes Care. 1998 Apr;21(4):487-93. doi: 10.2337/diacare.21.4.487. Diabetes Care. 1998. PMID: 9571329

9

Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.

Serri O, St-Jacques P, Sartippour M, Renier G. Serri O, et al. Among authors: renier g. J Clin Endocrinol Metab. 1999 Jan;84(1):58-63. doi: 10.1210/jcem.84.1.5374. J Clin Endocrinol Metab. 1999. PMID: 9920062 Clinical Trial.

10

Effect of gliclazide on monocyte-endothelium interactions in diabetes.

Renier G, Desfaits AC, Serri O. Renier G, et al. J Diabetes Complications. 2000 Jul-Aug;14(4):215-23. doi: 10.1016/s1056-8727(00)00082-9. J Diabetes Complications. 2000. PMID: 11004431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters